| 2.29 Data as of Jun 19 | -0.16 / -6.53%Today’s Change | 0.70 Today|||52-Week Range 2.76 | +201.32% Year-to-Date |
The 4 analysts offering 12-month price forecasts for Chelsea Therapeutics International Ltd have a median target of 4.00, with a high estimate of 7.00 and a low estimate of 3.50. The median estimate represents a +74.67% increase from the last price of 2.29.

The current consensus among 4 polled investment analysts is to Buy stock in Chelsea Therapeutics International Ltd. This rating has held steady since June, when it was unchanged from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




